These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. Harvey G; Black C; Maddison P; McHugh N J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652 [TBL] [Abstract][Full Text] [Related]
6. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. Mahler M; Raijmakers R Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Ulanet DB; Wigley FM; Gelber AC; Rosen A Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598 [TBL] [Abstract][Full Text] [Related]
8. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin). Falkner D; Wilson J; Fertig N; Clawson K; Medsger TA; Morel PA J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287 [TBL] [Abstract][Full Text] [Related]
9. [Diagnostic significance of scleroderma and myositis-associated autoantibodies]. Genth E; Mierau R Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809 [TBL] [Abstract][Full Text] [Related]
10. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex. Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121 [TBL] [Abstract][Full Text] [Related]
11. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Reimer G; Steen VD; Penning CA; Medsger TA; Tan EM Arthritis Rheum; 1988 Apr; 31(4):525-32. PubMed ID: 2451921 [TBL] [Abstract][Full Text] [Related]
12. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. Reimer G; Scheer U; Peters JM; Tan EM J Immunol; 1986 Dec; 137(12):3802-8. PubMed ID: 3537125 [TBL] [Abstract][Full Text] [Related]
14. [Serology in patients with scleroderma]. Ullman S; Halberg P; Høier-Madsen M; Kang L; Konstantinov K; Pedersen K; Rasmussen E; Wiik A Ugeskr Laeger; 1993 Feb; 155(7):472-6. PubMed ID: 8465453 [TBL] [Abstract][Full Text] [Related]
15. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Reveille JD; Solomon DH; Arthritis Rheum; 2003 Jun; 49(3):399-412. PubMed ID: 12794797 [No Abstract] [Full Text] [Related]
16. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Koenig M; Dieudé M; Senécal JL Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021 [TBL] [Abstract][Full Text] [Related]
18. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes]. Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267 [TBL] [Abstract][Full Text] [Related]
19. The clinical relevance of autoantibodies in scleroderma. Ho KT; Reveille JD Arthritis Res Ther; 2003; 5(2):80-93. PubMed ID: 12718748 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen. Mahler M; Fritzler MJ; Satoh M Autoimmun Rev; 2015 Mar; 14(3):254-7. PubMed ID: 25462581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]